Literature DB >> 12852436

Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles.

Martina Kempf1, Barnali Mandal, Samantha Jilek, Lars Thiele, Janos Vörös, Markus Textor, Hans P Merkle, Elke Walter.   

Abstract

Dendritic cells (DC) need to be stimulated before they can function to initiate immune responses. This study investigates whether microparticles loaded with antibodies specific for selected receptors expressed by DC can induce stimulation of these cells. Plain microparticles were compared with microparticles which were surface-loaded with specific antibodies for human CD40, Fc(gamma), alpha(v)beta3 and alpha(v)beta5 integrin receptors. The antibodies were either physically adsorbed or covalently linked to the microparticle surface. Anti-CD40 antibody and human IgG immobilised on the surface of microparticles induced enhanced DC maturation and activation as expressed by CD83 and CD86 upregulation. IL-12 secretion was induced at a detectable but relatively low level. Both anti-integrin antibodies (anti-alpha(v)beta3 and anti-alpha(v)beta5) induced comparable and considerable maturation of DC, but only anti-alpha(v)beta3 antibody induced significant activation of DC, whereas anti-alpha(v)beta5 did not. The stimulatory effects were most pronounced by employing microparticles with covalently linked antibodies, but were also observed to a minor extent when the antibodies were physically adsorbed to polystyrene and biodegradable poly(lactide-co-glycolide) microparticles. Engineering of microparticles by surface conjugation of specific ligands to stimulate DC may increase the effectiveness of microparticulate vaccine delivery systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852436     DOI: 10.1080/1061186031000072978

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  10 in total

Review 1.  Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.

Authors:  Benjamin G Keselowsky; Chang Qing Xia; Michael Clare-Salzler
Journal:  Hum Vaccin       Date:  2011-01-01

2.  Multiple and time-scheduled in situ DNA delivery mediated by beta-cyclodextrin embedded in a polyelectrolyte multilayer.

Authors:  N Jessel; M Oulad-Abdelghani; F Meyer; P Lavalle; Y Haîkel; P Schaaf; J-C Voegel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

Review 3.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

Review 4.  Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.

Authors:  Nitesh K Kunda; Satyanarayana Somavarapu; Stephen B Gordon; Gillian A Hutcheon; Imran Y Saleem
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

Review 5.  Nanomedicine approaches to improve cancer immunotherapy.

Authors:  Hui Qiu; Yuanzeng Min; Zach Rodgers; Longzhen Zhang; Andrew Z Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-10

6.  Microparticle surface modifications targeting dendritic cells for non-activating applications.

Authors:  Jamal S Lewis; Toral D Zaveri; Charles P Crooks; Benjamin G Keselowsky
Journal:  Biomaterials       Date:  2012-07-12       Impact factor: 12.479

Review 7.  Nanotechnology-based immunotherapies to combat cancer metastasis.

Authors:  Yuping Zhao; Muhammad Bilal; Maimoona Qindeel; Muhammad Imran Khan; Kuldeep Dhama; Hafiz M N Iqbal
Journal:  Mol Biol Rep       Date:  2021-08-23       Impact factor: 2.316

8.  Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.

Authors:  Mauricio A Arias; Andrew Loxley; Christy Eatmon; Griet Van Roey; David Fairhurst; Mark Mitchnick; Philip Dash; Tom Cole; Frank Wegmann; Quentin Sattentau; Robin Shattock
Journal:  Vaccine       Date:  2010-12-09       Impact factor: 3.641

9.  Recombinant Filamentous Bacteriophages Encapsulated in Biodegradable Polymeric Microparticles for Stimulation of Innate and Adaptive Immune Responses.

Authors:  Rezvan Jamaledin; Rossella Sartorius; Concetta Di Natale; Raffaele Vecchione; Piergiuseppe De Berardinis; Paolo Antonio Netti
Journal:  Microorganisms       Date:  2020-04-29

Review 10.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.